A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism is a research paper published in Bioorganic & Medicinal Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health Office of Extramural Research
Grant: R15GM110602
National Institutes of Health
Grant: 1R15GM110602-01A1
Novel Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Therapeutic Agents
National Institutes of Health
FWCI
1.12
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals